559 related articles for article (PubMed ID: 31045511)
1. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of miR-1236-3p is correlated with clinical progression and unfavorable prognosis in gastric cancer.
Zhu XP; Wang XL; Ma J; Fang YF; Zhang HJ; Zhang C; Feng MC
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5914-5919. PubMed ID: 30280772
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer.
Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
Cancer Biomark; 2017 Dec; 21(1):117-122. PubMed ID: 29060930
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer.
Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
Oncol Res Treat; 2020; 43(1-2):19-26. PubMed ID: 31743914
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and Prognostic Value of Serum miR-296-5p and miR-28-3p in Human Gastric Cancer.
Guo Y; Cui X; Zhang Y; Ma X; Ren A; Huang H
Cancer Biother Radiopharm; 2023 Mar; 38(2):95-101. PubMed ID: 32898433
[No Abstract] [Full Text] [Related]
6. Serum miR-200c expression level as a prognostic biomarker for gastric cancer.
Zhang HP; Sun FB; Li SJ
Genet Mol Res; 2015 Dec; 14(4):15913-20. PubMed ID: 26662382
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of candidate microRNAs in gastric cancer: A validation study.
Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P
Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of miR-141 downregulation in gastric cancer.
Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
Yang X; Zhang Z; Zhang L; Zhou L
Sci Rep; 2020 Mar; 10(1):4672. PubMed ID: 32170105
[TBL] [Abstract][Full Text] [Related]
11. Clinical potential of miR-940 as a diagnostic and prognostic biomarker in breast cancer patients.
Liu W; Xu Y; Guan H; Meng H
Cancer Biomark; 2018; 22(3):487-493. PubMed ID: 29843213
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
13. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
14. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
Li J; Zou X
Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
[TBL] [Abstract][Full Text] [Related]
15. Prognostic potential of miR-21-3p in gastric cancer.
Sun X; Zhang K; Li D
J BUON; 2020; 25(6):2678-2682. PubMed ID: 33455113
[TBL] [Abstract][Full Text] [Related]
16. miR-199a-3p and miR-214-3p improve the overall survival prediction of muscle-invasive bladder cancer patients after radical cystectomy.
Ecke TH; Stier K; Weickmann S; Zhao Z; Buckendahl L; Stephan C; Kilic E; Jung K
Cancer Med; 2017 Oct; 6(10):2252-2262. PubMed ID: 28879675
[TBL] [Abstract][Full Text] [Related]
17. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.
Li X; Jiang M; Chen D; Xu B; Wang R; Chu Y; Wang W; Zhou L; Lei Z; Nie Y; Fan D; Shang Y; Wu K; Liang J
J Exp Clin Cancer Res; 2018 Mar; 37(1):71. PubMed ID: 29587866
[TBL] [Abstract][Full Text] [Related]
18. Expression Levels of miR-127-3p and miR-144-3p in Gastric Cancer and their Relationships with Clinicopathological Parameters.
Sahami-Fard MH; Yazd EF; Jamalpoor Z; Nezhadi A
Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538067
[TBL] [Abstract][Full Text] [Related]
19. Circulating SHIP2 mRNA as a novel biomarker in the diagnosis and prognosis of gastric cancer.
Xie JF; Xie NS; Tang JH; Gu QP; Luo QT
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5129-5134. PubMed ID: 29228424
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of miR-330-3p: a novel independent indicator of poor prognosis in human breast cancer.
Wang H; Chen SH; Kong P; Zhang LY; Zhang LL; Zhang NQ; Gu H
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1726-1730. PubMed ID: 29630118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
